Strategies toward Renewable and Compostable Intravenous Bag Materials
ACS Applied Bio Materials · 2026
DOI: 10.1021/acsabm.5c02054 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Daniel M Krajovic und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota 55455, United States. Hauptthemen laut MEDLINE: Biocompatible Materials, Polyesters. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Division of Graduate Education, College of Science and Engineering, University of Minnesota, Medical School, University of Minnesota.
Abstract (Originalsprache)
The medical industry contributes significantly to single-use plastic waste, as illustrated most recently by the COVID-19 pandemic. While safety standards mandate the use of disposable, single-use items for the highest-value applications, there is an opportunity to pursue greater circularity in higher-volume, bulk plastic goods, including intravenous (IV) bags. Herein, we assessed two thermoplastic elastomers based on renewable, compostable poly(γ-methyl-ε-caprolactone) (PγMCL) as IV bag material alternatives to the nonrenewable, potentially harmful phthalate-plasticized poly(vinyl chloride) (PVC) industry standard. We synthesized a thermoplastic poly(urethane-urea) (TPUU) and 4-arm PγMCL- b -poly((−)-lactide) star-block polymer ((ML) 4 ) on >55 g scales and comprehensively evaluated their mechanical and (bio)chemical readiness for an IV bag application. The TPUU showed excellent mechanical parity with PVC, and both PγMCL-based materials displayed superior cytocompatibility to PVC. An in vivo implantation study in a rat model revealed no significantly adverse histopathology resulting from direct tissue contact with the TPUU or (ML) 4 . The PγMCL-based materials also conform to ISO-standardized chemical hazard thresholds similarly to PVC. Our work is the first to target IV bag waste through direct replacement of current materials with intrinsically circular polymers, providing an evaluation framework for future IV bag candidates and expanding PγMCL’s application scope to the biomedical sector.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota 55455, United States.
- Department of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.
- University of Minnesota Medical School, Minneapolis, Minnesota 55455, United States.
- University of Minnesota College of Veterinary Medicine, St. Paul, Minnesota 55108, United States.
- Division of Thoracic and Foregut Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota 55455, United States.
ORCID-Profile: Daniel M Krajovic, Margaret S Kumler, Marc A Hillmyer
Förderung
- Division of Graduate Education
- College of Science and Engineering, University of Minnesota
- Medical School, University of Minnesota
Zitieren
APA
Krajovic, D. M., Kumler, M. S., Gathman, T., Schoephoerster, J., Vasdev, R., Liffland, S. R., Batiste, D. C., Schappa Faustich, J., Andrade, R., & Hillmyer, M. A. (2026). Strategies toward Renewable and Compostable Intravenous Bag Materials. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c02054
Vancouver
Krajovic DM, Kumler MS, Gathman T, Schoephoerster J, Vasdev R, Liffland SR, et al. Strategies toward Renewable and Compostable Intravenous Bag Materials. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.5c02054
BibTeX
@article{Krajovic2026,
author = {Krajovic, Daniel M and Kumler, Margaret S and Gathman, Tyler and Schoephoerster, Jamee and Vasdev, Ranveer and Liffland, Stephanie R and Batiste, Derek C and Schappa Faustich, Jill and Andrade, Rafael and Hillmyer, Marc A},
title = {Strategies toward Renewable and Compostable Intravenous Bag Materials},
journal = {ACS Applied Bio Materials},
year = {2026},
doi = {10.1021/acsabm.5c02054}
}
EUVIMED